Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shadi Lalezari

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Magnetic Resonance Imaging : JMRI|January 28, 2012
Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomasBenjamin M Ellingson, Taryar Zaw, Timothy F Cloughesy, et al.
Journal of Neuro-Oncology|June 28, 2011
Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumabBenjamin M Ellingson, Timothy F Cloughesy, Albert Lai, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|March 31, 2016
Current concepts related to hypertrophic scarring in burn injuriesRyan S Chiang, Anna A Borovikova, Kassandra King, et al.
Neuroimage|October 18, 2011
Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: a radiographic study in 358 de novo human glioblastomasBenjamin M Ellingson, Timothy F Cloughesy, Whitney B Pope, et al.
Neuro-Oncology|January 25, 2012
Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastomaBenjamin M Ellingson, Timothy F Cloughesy, Taryar Zaw, et al.
Neuro-Oncology|March 15, 2014
Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacyDavid E Piccioni, Julia Selfridge, Reema R Mody, et al.
Journal of the National Cancer Institute|September 5, 2012
Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomasArthur P Chou, Reshmi Chowdhury, Sichen Li, et al.
Neuro-Oncology|January 19, 2013
Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcomeShadi Lalezari, Arthur P Chou, Anh Tran, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Magnetic Resonance Imaging : JMRI|January 28, 2012
Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomasBenjamin M Ellingson, Taryar Zaw, Timothy F Cloughesy, et al.
Journal of Neuro-Oncology|June 28, 2011
Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumabBenjamin M Ellingson, Timothy F Cloughesy, Albert Lai, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|March 31, 2016
Current concepts related to hypertrophic scarring in burn injuriesRyan S Chiang, Anna A Borovikova, Kassandra King, et al.
Neuroimage|October 18, 2011
Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: a radiographic study in 358 de novo human glioblastomasBenjamin M Ellingson, Timothy F Cloughesy, Whitney B Pope, et al.
Neuro-Oncology|January 25, 2012
Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastomaBenjamin M Ellingson, Timothy F Cloughesy, Taryar Zaw, et al.
Neuro-Oncology|March 15, 2014
Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacyDavid E Piccioni, Julia Selfridge, Reema R Mody, et al.
Journal of the National Cancer Institute|September 5, 2012
Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomasArthur P Chou, Reshmi Chowdhury, Sichen Li, et al.
Neuro-Oncology|January 19, 2013
Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcomeShadi Lalezari, Arthur P Chou, Anh Tran, et al.
Pageof 2